SCHEMBL26092309

SCHEMBL26092309

CC(C)(C)OC(=O)N1CCN(Cc2cccc(Cl)c2)c2ccccc21

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 2/20 0.67
▸ HDAC6 Q9UBN7 2/20 0.67
▸ BRD4 O60885 2/20 0.54
▸ AMPD2 Q01433 1/20 0.47
▸ P2RX7 Q99572 1/20 0.44
▸ MAPT P10636 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ DRD2 P14416 3/20 0.43
▸ DRD4 P21917 2/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ SIGMAR1 Q99720 1/20 0.42
▸ DRD3 P35462 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ KCNQ2 O43526 2/20 0.41
▸ KDM1A O60341 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30673916 1.00 HDAC1 (0.67) HDAC1HDAC6BRD4AMPD2P2RX7
SCHEMBL30910107 1.00 HDAC1 (0.67) HDAC1HDAC6BRD4AMPD2P2RX7
SCHEMBL19225201 0.90 HDAC1 (0.77) HDAC1HDAC6BRD4CYP2C9CYP2C19
SCHEMBL30910116 0.89 HDAC1 (0.76) HDAC1HDAC6BRD4AMPD2P2RX7
SCHEMBL26089401 0.89 HDAC1 (0.76) HDAC1HDAC6BRD4AMPD2P2RX7
SCHEMBL31631249 0.87 HDAC1 (0.64) HDAC1HDAC6BRD4CYP2C9CYP2C19
SCHEMBL31631234 0.83 HDAC1 (0.74) HDAC1HDAC6BRD4DRD2DRD4
SCHEMBL26933828 0.83 HDAC1 (0.74) HDAC1HDAC6BRD4DRD2DRD4
SCHEMBL30910094 0.81 HDAC1 (0.65) HDAC1HDAC6BRD4AMPD2P2RX7
SCHEMBL26088818 0.81 HDAC1 (0.65) HDAC1HDAC6BRD4AMPD2P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4538270-A1 NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT Sapiensbio Inc. (KR) 2025-04-16 — — EP disclosed
CN-118119612-A Novel compounds and pharmaceutical compositions comprising the same 萨皮恩斯生物有限公司 2024-05-31 — — CN disclosed
WO-2023239227-A1 NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT 주식회사 사피엔스바이오 2023-12-14 — — WO disclosed
WO-2023068755-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 사피엔스바이오 2023-04-27 — — WO disclosed
Send feedback